NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) | PAR 23 183

Frequently Asked Questions (FAQs)

1) What is the name of this grant opportunity?

The opportunity is titled "NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)."

2) Which agency is offering this funding?

The funding is offered by the National Library of Medicine (NLM), which is part of the National Institutes of Health (NIH).

3) What is the funding opportunity number (NOFO number)?

The funding opportunity number is PAR 23 183.

4) What is the main purpose of this grant program?

This is a discretionary grant program designed to support the development and preparation of book-length manuscripts and similar substantial scholarly works that have clear academic value or public health importance in biomedicine, health, and the health sciences.

5) What types of projects are a strong fit for this opportunity?

Projects focused on producing a rigorous, high-impact written scholarly product are the central fit. The announcement emphasizes book-length manuscripts, and it also allows for other major scholarly works of comparable scope and significance, as long as they align with the program's educational and health-related goals.

6) Is this grant intended to fund clinical trials?

No. The opportunity is marked "Clinical Trial Not Allowed." Proposals that include or propose clinical trials would not fit this program.

7) Is this a research grant or a writing/scholarly production grant?

Based on the description provided, it is best understood as a writing and scholarly production grant that supports preparing a substantial manuscript or similar scholarly product, rather than a program intended to fund research trials.

8) What kinds of final products does NLM want to support?

The core focus is on book-length manuscripts. The language also mentions "other works" with scholarly or public health significance, suggesting NLM may support substantial scholarly outputs beyond books when they are comparable in scope and contribution and clearly relevant to biomedicine, health, or public health.

9) Who is the intended audience for the finished work?

The intended audience includes U.S. health professionals, public health officials, biomedical researchers, and historians of the health sciences.

10) What subject areas or themes are relevant for this program?

The program supports scholarly works in biomedicine, health, and the health sciences. Works should have clear academic value or public health importance and be capable of informing professional practice, public health understanding, biomedical research, or historical scholarship in the health sciences.

11) What is the funding activity category listed for this opportunity?

The funding activity category is listed under Education and Health.

12) What is the Assistance Listing (CFDA) number?

The associated CFDA (assistance listing) number is 93.879.

13) What is the maximum award amount (award ceiling)?

The award ceiling shown in the summary data is $75,000, meaning this is the maximum award amount anticipated per grant under the posted summary information.

14) When is the closing date or submission deadline?

The original closing date listed is 2026-02-26. Applicants should plan around this deadline when preparing their submission timeline.

15) How many awards will be made?

The provided information does not specify an expected number of awards. Applicants should not assume a particular success rate based on the summary alone and should rely on the full NOFO and NIH guidance for any competitiveness expectations.

16) Who is eligible to apply?

Eligibility is broad and includes many organization types across the public, private, nonprofit, and academic sectors, as well as additional categories explicitly highlighted in the announcement.

17) Are state and local governments eligible?

Yes. Eligible applicants include state governments, county governments, city or township governments, and special district governments.

18) Are public and private colleges and universities eligible?

Yes. Public and state-controlled institutions of higher education and private institutions of higher education are listed as eligible.

19) Are school districts eligible to apply?

Yes. Independent school districts are listed among eligible applicants.

20) Are Native American tribal governments and tribal organizations eligible?

Yes. Federally recognized Native American tribal governments are eligible, and Native American tribal organizations (other than federally recognized tribal governments) are also eligible. The opportunity also highlights tribal governments other than federally recognized as eligible applicant types.

21) Are nonprofits eligible?

Yes. A wide range of nonprofit organizations are eligible, including 501(c)(3) and non-501(c)(3) nonprofits (with the noted exclusion language about institutions of higher education when specified in those nonprofit categories).

22) Are for-profit organizations eligible?

Yes. For-profit organizations (other than small businesses) are eligible, and small businesses are also listed as eligible.

23) Are public housing authorities eligible?

Yes. Public housing authorities/Indian housing authorities are included as eligible applicants.

24) Are U.S. territories or possessions eligible?

Yes. The opportunity explicitly highlights U.S. territories or possessions as eligible applicant types.

25) Are non-U.S. (foreign) organizations eligible to apply?

Yes. Non-U.S. (foreign) organizations are explicitly listed among the eligible applicant types.

26) Are federally affiliated entities eligible?

Yes. The opportunity highlights eligible federal government agencies as eligible applicant types.

27) Does the opportunity encourage applications from specific institution types?

Yes. The description explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).

28) Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are explicitly highlighted as eligible applicant types.

29) What does "Clinical Trial Not Allowed" mean for applicants?

It means proposals that include conducting a clinical trial are out of scope for this opportunity. The program is positioned around producing a major manuscript or comparable scholarly work, not running clinical trial activities.

30) What is the best overall way to think about this grant?

It is support for producing a substantial, well-argued, well-documented scholarly work in biomedicine, health, or the health sciences that will matter to biomedical and public health audiences in the United States, including those working in practice, policy, research, and the history of medicine and health sciences.